137 related articles for article (PubMed ID: 24368216)
1. Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Kan QC; Zhang S; Xu YM; Zhang GX; Zhu L
Neurosci Lett; 2014 Feb; 560():92-7. PubMed ID: 24368216
[TBL] [Abstract][Full Text] [Related]
2. Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.
Zhao X; Zhang X; Lv Y; Xu Y; Li M; Pan Q; Chu Y; Liu N; Zhang GX; Zhu L
Immunol Lett; 2016 Oct; 178():97-104. PubMed ID: 27562326
[TBL] [Abstract][Full Text] [Related]
3. Matrine protects neuro-axon from CNS inflammation-induced injury.
Kan QC; Lv P; Zhang XJ; Xu YM; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Feb; 98(1):124-30. PubMed ID: 25576296
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis.
Chu Y; Jing Y; Zhao X; Wang M; Zhang M; Ma R; Ma W; Lv Y; Zhu L
J Neuroimmunol; 2021 Mar; 352():577480. PubMed ID: 33493985
[TBL] [Abstract][Full Text] [Related]
5. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.
Mitosek-Szewczyk K; Sulkowski G; Stelmasiak Z; Struzyńska L
Neuroscience; 2008 Jul; 155(1):45-52. PubMed ID: 18572325
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling.
Zhu L; Pan QX; Zhang XJ; Xu YM; Chu YJ; Liu N; Lv P; Zhang GX; Kan QC
Exp Mol Pathol; 2016 Apr; 100(2):337-43. PubMed ID: 26681653
[TBL] [Abstract][Full Text] [Related]
7. Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.
Ma W; Zhang M; Liu S; Wang M; Shi Y; Yang T; Li X; Zhu L
Neurosci Lett; 2020 Jan; 715():134599. PubMed ID: 31722234
[TBL] [Abstract][Full Text] [Related]
8. Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis.
Kan QC; Zhang HJ; Zhang Y; Li X; Xu YM; Thome R; Zhang ML; Liu N; Chu YJ; Zhang GX; Zhu L
Mol Neurobiol; 2017 Dec; 54(10):8404-8418. PubMed ID: 27933584
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis.
Liu N; Kan QC; Zhang XJ; Xv YM; Zhang S; Zhang GX; Zhu L
Exp Mol Pathol; 2014 Dec; 97(3):470-6. PubMed ID: 25303900
[TBL] [Abstract][Full Text] [Related]
10. Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Kan QC; Pan QX; Zhang XJ; Chu YJ; Liu N; Lv P; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Oct; 99(2):212-9. PubMed ID: 26093163
[TBL] [Abstract][Full Text] [Related]
11. Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.
Sulkowski G; Dąbrowska-Bouta B; Salińska E; Strużyńska L
PLoS One; 2014; 9(11):e113954. PubMed ID: 25426719
[TBL] [Abstract][Full Text] [Related]
12. Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism.
Chu YJ; Ma WD; Thome R; Ping JD; Liu FZ; Wang MR; Zhang ML; Zhang G; Zhu L
Front Immunol; 2020; 11():569530. PubMed ID: 33101289
[TBL] [Abstract][Full Text] [Related]
13. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
14. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Kan QC; Zhu L; Liu N; Zhang GX
Immunol Res; 2013 May; 56(1):189-96. PubMed ID: 23549837
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Zhang S; Kan QC; Xu Y; Zhang GX; Zhu L
Mediators Inflamm; 2013; 2013():736085. PubMed ID: 24194630
[TBL] [Abstract][Full Text] [Related]
16. Matrine inhibits the Wnt3a/β-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis.
Ma R; Chu Y; Dou M; Jing Y; Zhao X; Li X; Li S; Zhang Y; Wang L; Zhu L
J Neuroimmunol; 2022 Jun; 367():577876. PubMed ID: 35489221
[TBL] [Abstract][Full Text] [Related]
17. Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis.
Zhao X; Kan Q; Zhu L; Zhang GX
Am J Chin Med; 2011; 39(5):933-41. PubMed ID: 21905283
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.
Gentile A; Musella A; De Vito F; Fresegna D; Bullitta S; Rizzo FR; Centonze D; Mandolesi G
J Neuroinflammation; 2018 Jan; 15(1):5. PubMed ID: 29304807
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis.
Ohgoh M; Hanada T; Smith T; Hashimoto T; Ueno M; Yamanishi Y; Watanabe M; Nishizawa Y
J Neuroimmunol; 2002 Apr; 125(1-2):170-8. PubMed ID: 11960654
[TBL] [Abstract][Full Text] [Related]
20. Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis.
Zhang ML; Zhang XJ; Kang J; Zhang HJ; Chen XL; Liu N; Liu SQ; Ma WD; Zhang GX; Zhu L
Neurosci Lett; 2017 May; 649():100-106. PubMed ID: 28392360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
